Clinical Trials Browser

IMC-001 × Lymphoid × 90 days × Clear all

NCT04414163 2026-04-24

A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type

Phase 2 Active not recruiting

Lymphoma, Extranodal NK-T-Cell